This brand name is authorized in Ecuador.
The drug BROXOLAM COMPUESTO contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
CC995ZMV90 - AMBROXOL HYDROCHLORIDE
|
|
Ambroxol induces activation of the surfactant system by acting directly on the type II pneumocytes of the alveoles and the Clara cells in the region of the small airways. It promotes the formation and outward transfer of surface-active material in the alveolar and bronchial region of the foetal and adult lungs. |
|
2
|
UNII
GOR5747GWU - CLENBUTEROL HYDROCHLORIDE
|
|
Clenbuterol is a direct-acting β2 sympathomimetic agent for the treatment of chronic obstructive airway diseases. |
|
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 01985-MAC-05-02, 03082-MAN-05-04 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.